Effect of macrophage migration inhibitory factor on pulmonary vein arrhythmogenesis through late sodium current
EP Europace · 2023
DOI: 10.1093/europace/euac152 ↗Kurz gefasst
Fachartikel in der Zeitschrift EP Europace, 2023. Verfasst von Chye-Gen Chin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Pulmonary Veins, Macrophage Migration-Inhibitory Factors, Atrial Fibrillation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taipei Medical University-Wanfang Hospital, Ministry of National Defense-Medical Affairs Bureau.
Abstract (Originalsprache)
Aims
Macrophage migration inhibitory factor (MIF), a pleiotropic inflammatory cytokine, is highly expressed in patients with atrial fibrillation (AF). Inflammation increases the risk of AF and is primarily triggered by pulmonary vein (PV) arrhythmogenesis. This study investigated whether MIF can modulate the electrical activity of the PV and examined the underlying mechanisms of MIF. Methods and results A conventional microelectrode, a whole-cell patch clamp, western blotting, and immunofluorescent confocal microscopy were used to investigate electrical activity, calcium (Ca2+) regulation, protein expression, ionic currents, and cytosolic reactive oxygen species (ROS) in rabbit PV tissue and isolated single cardiomyocytes with and without MIF incubation (100 ng/mL, treated for 6 h). The MIF (100 ng/mL)-treated PV tissue (n = 8) demonstrated a faster beating rate (1.8 ± 0.2 vs. 2.6 ± 0.1 Hz, P < 0.05), higher incidence of triggered activity (12.5 vs. 100%, P < 0.05), and premature atrial beat (0 vs. 100%, P < 0.05) than the control PV tissue (n = 8). Compared with the control PV cardiomyocytes, MIF-treated single PV cardiomyocytes had larger Ca2+ transients (0.6 ± 0.1 vs. 1.0 ± 0.1, ΔF/F0, P < 0.05), sarcoplasmic reticulum Ca2+ content (0.9 ± 0.20 vs. 1.7 ± 0.3 mM of cytosol, P < 0.05), and cytosolic ROS (146.8 ± 5.3 vs. 163.7 ± 3.8, ΔF/F0, P < 0.05). Moreover, MIF-treated PV cardiomyocytes exhibited larger late sodium currents (INa-Late), L-type Ca2+ currents, and Na+/Ca2+ exchanger currents than the control PV cardiomyocytes. KN93 [a selective calcium/calmodulin-dependent protein kinase II (CaMKII) blocker, 1 μM], ranolazine (an INa-Late inhibitor, 10 μM), and N-(mercaptopropionyl) glycine (ROS inhibitor, 10 mM) reduced the beating rates and the incidence of triggered activity and premature captures in the MIF-treated PV tissue.
Conclusion
Macrophage migration inhibitory factor increased PV arrhythmogenesis through Na+ and Ca2+ dysregulation through the ROS activation of CaMKII signalling, which may contribute to the genesis of AF during inflammation. Anti-CaMKII treatment may reverse PV arrhythmogenesis. Our results clearly reveal a key link between MIF and AF and offer a viable therapeutic target for AF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei 11031, Taiwan.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- Department of Biomedical Engineering, National Defense Medical Center, Taipei, Taiwan.
- Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Division of Cardiology, Department of Internal Medicine, Sijhih Cathay General Hospital, New Taipei City, Taiwan.
- Division of Cardiovascular Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Chye-Gen Chin, Yao-Chang Chen, Yen-Yu Lu, Wan-Li Cheng, Shih-Ann Chen, Yi-Jen Chen
Förderung
- Ministry of Science and Technology
- Taipei Medical University-Wanfang Hospital
- Ministry of National Defense-Medical Affairs Bureau
- Taipei Medical University–Wanfang Hospital
- Ministry of National Defense–Medical Affairs Bureau
Zitieren
APA
Chin, C. G., Chen, Y. C., Lin, Y. K., Lu, Y. Y., Cheng, W. L., Chung, C. C., Chen, S. A., & Chen, Y. J. (2023). Effect of macrophage migration inhibitory factor on pulmonary vein arrhythmogenesis through late sodium current. EP Europace. https://doi.org/10.1093/europace/euac152
Vancouver
Chin CG, Chen YC, Lin YK, Lu YY, Cheng WL, Chung CC, et al. Effect of macrophage migration inhibitory factor on pulmonary vein arrhythmogenesis through late sodium current. EP Europace. 2023. doi:10.1093/europace/euac152
BibTeX
@article{Chin2023,
author = {Chin, Chye-Gen and Chen, Yao-Chang and Lin, Yung-Kuo and Lu, Yen-Yu and Cheng, Wan-Li and Chung, Cheng-Chih and Chen, Shih-Ann and Chen, Yi-Jen},
title = {Effect of macrophage migration inhibitory factor on pulmonary vein arrhythmogenesis through late sodium current},
journal = {EP Europace},
year = {2023},
doi = {10.1093/europace/euac152}
}
EUVIMED